Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY – Get Free Report)’s share price gapped up before the market opened on Monday. The stock had previously closed at $11.95, but opened at $12.78. Santen Pharmaceutical shares last traded at $12.7288, with a volume of 1,074 shares.
Santen Pharmaceutical Price Performance
The firm has a 50-day simple moving average of $11.16 and a 200 day simple moving average of $11.53.
Santen Pharmaceutical Company Profile
Santen Pharmaceutical is a Japan-based pharmaceutical company focused on eye care. Founded in 1890, it researches, develops, manufactures and markets treatments for ophthalmic conditions. Its products include prescription medicines for conditions such as glaucoma, dry eye and retinal diseases, as well as over-the-counter eye drops and other eye-care products. The company also offers products for eye surgery and related medical needs. Headquartered in Osaka, Santen serves patients and healthcare professionals in Japan and international markets, including other parts of Asia, Europe and the Middle East and Africa.
Recommended Stories
- Five stocks we like better than Santen Pharmaceutical
- Anthropic’s Trillion-Dollar IPO Could Give Cloud Giants a Double Win
- The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom
- 3 Insider Selling Stories; 3 Different Signals for Investors
- The Trade Desk Beats on Revenue, But the Fine Print Matters
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
